Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Apnimed is raising $15,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Lawrence Miller played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Apnimed

Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders. Apnimed, Inc. was founded in 2017 and is located in Cambridge, MA.

To learn more about Apnimed, visit http://apnimed.com/

Contact:
Lawrence Miller, President and Chief Executive Officer
617-500-8880
https://www.linkedin.com/in/lawrence-miller-9b652b10/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved